Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults

JAMA Internal Medicine

Volumn 174, Issue 4, 2014, Pages 588-595

  Tinetti, Mary E ^a,b   Han, Ling ^a   Lee, David S H ^c   McAvay, Gail J ^a   Peduzzi, Peter ^b   Gross, Cary P ^a   Zhou, Bingqing ^b   Lin, Haiqun ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

AGED; ANKLE FRACTURE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CERVICAL SPINE FRACTURE; COMMUNITY LIVING; FACE FRACTURE; FALLING; FEMALE; FIBULA FRACTURE; FOLLOW UP; FOREARM FRACTURE; FRACTURE; HIP DISLOCATION; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; HYPERTENSION; INJURY; JAW DISEASE; JAW DISLOCATION; JOINT DISLOCATION; KNEE DISLOCATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PELVIS FRACTURE; PRIORITY JOURNAL; PROPENSITY SCORE; RISK ASSESSMENT; SHOULDER DISLOCATION; SKULL FRACTURE; TIBIA FRACTURE; TRAUMATIC BRAIN INJURY; VERY ELDERLY;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); FEMALE; HUMANS; MALE; PROPENSITY SCORE; RISK; UNITED STATES; WOUNDS AND INJURIES;

EID: 84897509106     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.14764     Document Type: Article

References (52)

1. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation. 2012;126(17):2105-2114.
2. Smith SC Jr, Benjamin EJ, Bonow RO, et al;World Heart Federation; Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458- 2473.
3. Goldstein LB, Bushnell CD, Adams RJ, et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517-584.
4. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
5. AronowWS, Fleg JL, Pepine CJ, et al; ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123(21):2434-2506.
6. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;(4): CD000028.
7. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med. 2008;168(2):136-140.
8. Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233-1240.
9. Vokó Z, BotsML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34(6):1181-1185.
10. Ogihara T, Matsuoka H, Rakugi H. Practitioner's trial on the efficacy of antihypertensive treatment in elderly patients with hypertension II (PATE-Hypertension II study) in Japan. Geriatr Gerontol Int. 2011;11(4):414-421.
11. Denardo SJ, Gong Y, NicholsWW, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123(8):719-726.
12. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144(12):884-893.
13. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115-2127.
14. Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, et al. Treatment of hypertension in patients 80 years and older: the lower the better? a meta-analysis of randomized controlled trials. J Hypertens. 2010;28(7):1366- 1372.
15. Tinetti ME, McAvay G, Fried TR, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J AmGeriatr Soc. 2008;56(8):1409-1416.
16. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556-1564.
17. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107-1116.
18. Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 1999;33(11):1147-1153.
19. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J AmGeriatr Soc. 2004;52(8):1349-1354.
20. Gray SL, Sager M, LesticoMR, JalaluddinM. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci. 1998;53(1):M59-M63.
21. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952-1960.
22. Gribbin J, Hubbard R, Gladman JRF, Smith C, Lewis S. Risk of falls associated with antihypertensive medication: population-based case-control study. Age Ageing. 2010;39(5): 592-597.
23. Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172(22):1739-1744.
24. Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S. Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf. 2011;20(8):879-884.
25. Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y. Diuretic initiation and the acute risk of hip fracture. Osteoporos Int. 2013;24(2):689-695.
26. Solomon DH, Mogun H, Garneau K, Fischer MA. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res. 2011;26(7):1561-1567.
27. Medicare Current Beneficiary Survey (MCBS). http://www.cms.gov/Research- Statistics-Data-and -Systems/Research/MCBS/index.html. Accessed August 15, 2013.
28. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
29. Wessling A, Boëthius G. Measurement of drug use in a defined population: evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol. 1990;39(3):207-210.
30. Tinetti ME, Doucette J, Claus E, Marottoli R. Risk factors for serious injury during falls by older persons in the community. J AmGeriatr Soc. 1995;43(11):1214-1221.
31. D'Agostino RB Jr. Propensity scoremethods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
32. Faries DE, Leon AC, Maria Haro J, Obenchain RL, eds. Analysis of Observational Health Care Data Using SAS. Cary, NC: SAS Institute; 2010.
33. Leon AC, Hedeker D, Teres JJ. Bias reduction in effectiveness analyses of longitudinal ordinal doses with amixed-effects propensity adjustment. Stat Med. 2007;26(1):110-123.
34. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc; 1999.
35. Hosmer DWJ, Lemeshow S, eds. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons; 1999.
36. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459. 1999.10474144.
37. Kohl M, Heinze G. PSHREG: A SAS Macro for Proportional and Nonproportional Subdistribution Hazards RegressionWith Competing Risk Data. Vienna, Austria: Medical University of Vienna; 2012. Technical report 08/2012.
38. Xu R, O'Quigley J. Estimating average regression effect under non-proportional hazards. Biostatistics. 2000;1(4):423-439.
39. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008;27(12):2037-2049.
40. Rozenfeld S, Camacho LA, Veras P. Medication as a risk factor for falls in older women in Brazil. Rev Panam Salud Publica. 2003;13(6):369-375.
41. Leipzig RM, Cumming RG, TinettiME. Drugs and falls in older people: a systematic review and meta-analysis, II: cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47(1):40-50.
42. Tajeu GS, Delzell E, SmithW, et al. Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci. 2013. doi:10.1093/gerona/glt105.
43. Coronado VG, Xu L, Basavaraju SV, et al; Centers for Disease Control and Prevention (CDC). Surveillance for traumatic brain injury-related deaths-United States, 1997-2007. MMWR Surveill Summ. 2011;60(5):1-32.
44. Kuo H-K, Sorond F, Iloputaife I, Gagnon M, MilbergW, Lipsitz LA. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci. 2004;59(11):1191-1194.
45. Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the Maintenance of Balance, Independent Living, Intellect, and Zest in the Elderly of Boston Study. J AmGeriatr Soc. 2011;59(3):383-389.
46. Hajjar I, HartM, Chen YL, et al. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial. Arch Intern Med. 2012;172(5):442-444.
47. Agostini JV, Han L, TinettiME. The relationship between number of medications and weight loss or impaired balance in older adults. J AmGeriatr Soc. 2004;52(10):1719-1723
48. Barrett M, Steiner C. Addendum to healthcare cost and utilization project (HCUP) E code evaluation report (updated for 2009). HCUP Methods Series Report 2004-06. November 1, 2011. US Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports /methods/2004-06-add-09.pdf. Accessed September 14, 2013.
49. Zhou B, Fine J, Latouche A, Labopin M. Competing risks regression for clustered data. Biostatistics. 2012;13(3):371-383.
50. Johnson ES, Bartman BA, Briesacher BA, et al. The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2013;22(1):1-6.
51. Fried TR, McGraw S, Agostini JV, TinettiME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J AmGeriatr Soc. 2008;56(10):1839-1844.
52. Fried TR, Tinetti ME, Towle V, O'Leary JR, Iannone L. Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention. Arch Intern Med. 2011;171(10):923-928.